Hangzhou Tigermed
A contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Launch date
Employees
Market cap
€4.9b
Enterprise valuation
€5.0b (Public information from Sep 2024)
Share price
CNY49.73 300347.SZ
小营街道 Zhejiang (HQ)
No columns specified